LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028

$1,500$2,200

According to CRI’s report, it is calculated that Latin America sequencing reagents market will grow at a CAGR of 11.81% based on revenue during the assessed years of 2021-2028.

SKU: TR-481-2021 Category: Tag:

Description

LATIN AMERICA SEQUENCING REAGENTS MARKET OUTLOOK

According to CRI’s report, it is calculated that the sequencing reagents market in Latin America will grow at a CAGR of 11.81% based on revenue during the assessed years of 2021-2028. Brazil, Mexico, and Rest of Latin America shape the overall market in this region.

In Brazil, the biotechnology industry has witnessed several activities in the healthcare and industrial sectors. Moreover, the country is known for its research and investment in industrial biotechnology, mainly relating to cellulosic sugars and agribusiness. Several stakeholders, policymakers, and public investors have promoted the advancement of industrial biotechnology across the country.

Additionally, the trade groups in the country aim to improve the present patent laws to support biotechnology advancements, R&D, laboratory infrastructures, and others. Thus, the growth in biotechnology is anticipated to widen the scope of the sequencing reagents market.

Further, Mexico is striving to adopt new genomics techniques. Several local organizations are conducting seminars across the country to increase awareness about new genomic technologies.

For instance, the Center for Genomic Sciences and the Institute of Biotechnology introduced a series of seminars called ‘Frontiers in Genomics.’ It discusses functional, evolutionary, bacterial, computational, and human genomics, along with experimental analysis and technology. Therefore, efforts to raise awareness relating to developments in genomics are likely to offer opportunities to the sequencing reagents market in Mexico.

COMPETITIVE OUTLOOK

Major firms in the sequencing reagents market are Asuragen Inc, Merck KGAA, Thermo Fisher Scientific Inc, Pacific Biosciences of California Inc, Illumina Inc, Fluidigm Corporation, and Takara Bio Inc.

TABLE OF CONTENTS

1. LATIN AMERICA SEQUENCING REAGENTS MAREKT – SUMMARY

2. INDUSTRY OUTLOOK
2.1. IMPACT OF COVID-19 ON SEQUENCING REAGENTS MARKET
2.2. KEY INSIGHTS
2.3. PORTER’S FIVE FORCES MODEL
2.3.1. THREAT OF NEW ENTRANTS
2.3.2. THREAT OF SUBSTITUTE PRODUCTS
2.3.3. BARGAINING POWER OF BUYERSDS
2.3.4. BARGAINING POWER OF SUPPLIERS
2.3.5. COMPETITIVE RIVALRY
2.4. SUPPLY CHAIN OUTLOOK
2.5. MARKET ATTRACTIVENESS INDEX
2.6. VENDOR SCORECARD
2.7. KEY STRATEGIC DEVELOPMENTS
2.7.1. CONTRACTS AND PARTNERSHIPS
2.7.2. BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
2.7.3. ACQUISITIONS & MERGERS
2.7.4. NEW PRODUCT LAUNCHES & DEVELOPMENTS
2.8. MARKET DRIVERS
2.8.1. ONGOING RESEARCH IN GENOMICS DUE TO THE PREVALENCE OF CHRONIC DISEASES
2.8.2. ADVANCES IN GENOMICS AFTER THE LAUNCH OF NEW TECHNOLOGIES
2.9. MARKET CHALLENGES
2.9.1. SOCIAL AND ETHICAL ISSUES RELATED TO DATA PRIVACY
2.9.2. LACK OF PROFESSIONALS IN DEVELOPING COUNTRIES
2.10. MARKET OPPORTUNITIES
2.10.1. FUNDING BY MANUFACTURERS AND GOVERNMENT IN GENOMICS
2.10.2. GROWING DEMAND FOR THIRD-GENERATION SEQUENCING

3. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY APPLICATION
3.1. ONCOLOGY
3.2. CLINICAL INVESTIGATION
3.3. AGRI GENOMICS AND FORENSICS
3.4. REPRODUCTIVE HEALTH
3.5. OTHER APPLICATIONS

4. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY REAGENT TYPE
4.1. SEQUENCING KITS
4.2. CONTROL KITS
4.3. LIBRARY KITS
4.4. TEMPLATE KITS
4.5. OTHER REAGENT TYPES

5. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY TECHNOLOGY
5.1. NEXT-GENERATION SEQUENCING
5.2. SANGER SEQUENCING
5.3. THIRD-GENERATION SEQUENCING

6. LATIN AMERICA SEQUENCING REAGENTS MARKET – BY INDUSTRY VERTICALS
6.1. RESEARCH INSTITUTES
6.2. HOSPITALS AND CLINICS
6.3. PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES
6.4. OTHER INDUSTRY VERTICALS

7. LATIN AMERICA SEQUENCING REAGENTS MARKET – COUNTRY OUTLOOK
7.1. COUNTRY ANALYSIS
7.1.1. BRAZIL
7.1.2. MEXICO
7.1.3. REST OF LATIN AMERICA

8. COMPANY PROFILE
8.1. AGILENT TECHNOLOGIES INC
8.2. ASURAGEN INC
8.3. BGI GENOMICS
8.4. BIO RAD LABORATORIES INC
8.5. F HOFFMANN-LA ROCHE
8.6. FLUIDIGM CORPORATION
8.7. ILLUMINA INC
8.8. LGC BIOSEARCH TECHNOLOGIES
8.9. MERCK KGAA
8.10. PACIFIC BIOSCIENCES OF CALIFORNIA INC
8.11. PERKINELMER INC
8.12. QIAGEN NV
8.13. TAKARA BIO INC
8.14. THERMO FISHER SCIENTIFIC INC
8.15. TRILINK BIOTECHNOLOGIES INC

9. RESEARCH METHODOLOGY & SCOPE
9.1. RESEARCH SCOPE & DELIVERABLES
9.1.1. OBJECTIVES OF STUDY
9.1.2. SCOPE OF STUDY
9.2. SOURCES OF DATA
9.2.1. PRIMARY DATA SOURCES
9.2.2. SECONDARY DATA SOURCES
9.3. RESEARCH METHODOLOGY
9.3.1. EVALUATION OF PROPOSED MARKET
9.3.2. IDENTIFICATION OF DATA SOURCES
9.3.3. ASSESSMENT OF MARKET DETERMINANTS
9.3.4. DATA COLLECTION
9.3.5. DATA VALIDATION & ANALYSIS

LIST OF TABLES

TABLE 1: LATIN AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF CONTRACTS AND PARTNERSHIPS
TABLE 4: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
TABLE 5: LIST OF ACQUISITIONS & MERGERS
TABLE 6: LIST OF NEW PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 7: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2021-2028 (IN $ MILLION)
TABLE 8: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 9: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2021-2028 (IN $ MILLION)
TABLE 10: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
TABLE 11: LATIN AMERICA SEQUENCING REAGENTS MARKET, COUNTRY OUTLOOK, 2021-2028 (IN $ MILLION)

LIST OF FIGURES

FIGURE 1: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY APPLICATION, 2020 & 2028 (IN %)
FIGURE 2: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY ONCOLOGY, 2021-2028 (IN $ MILLION)
FIGURE 3: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY CLINICAL INVESTIGATION, 2021-2028 (IN $ MILLION)
FIGURE 4: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY AGRI GENOMICS AND FORENSICS, 2021-2028 (IN $ MILLION)
FIGURE 5: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)
FIGURE 6: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 7: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY REAGENT TYPE, 2020 & 2028 (IN %)
FIGURE 8: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY SEQUENCING KITS, 2021-2028 (IN $ MILLION)
FIGURE 9: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY CONTROL KITS, 2021-2028 (IN $ MILLION)
FIGURE 10: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY LIBRARY KITS, 2021-2028 (IN $ MILLION)
FIGURE 11: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TEMPLATE KITS, 2021-2028 (IN $ MILLION)
FIGURE 12: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER REAGENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 13: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY TECHNOLOGY, 2020 & 2028 (IN %)
FIGURE 14: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY NEXT-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 15: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY SANGER SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 16: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY THIRD-GENERATION SEQUENCING, 2021-2028 (IN $ MILLION)
FIGURE 17: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY INDUSTRY VERTICALS, 2020 & 2028 (IN %)
FIGURE 18: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY RESEARCH INSTITUTES, 2021-2028 (IN $ MILLION)
FIGURE 19: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY HOSPITALS AND CLINICS, 2021-2028 (IN $ MILLION)
FIGURE 20: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)
FIGURE 21: LATIN AMERICA SEQUENCING REAGENTS MARKET, BY OTHER INDUSTRY VERTICALS, 2021-2028 (IN $ MILLION)
FIGURE 22: BRAZIL SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 23: MEXICO SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)
FIGURE 24: REST OF LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028 (IN $ MILLION)

Additional information

Publisher

Geography Covered

Date Published

Pages

Format

Reviews

There are no reviews yet.

Be the first to review “LATIN AMERICA SEQUENCING REAGENTS MARKET 2021-2028”